Literature DB >> 18958543

Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Mitsushige Sugimoto1, Takahisa Furuta, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Haruhiko Sugimura, Akira Hishida.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) are a family of enzymes that degrade most macromolecules making up the extracellular matrix. MMPs are involved in not only the gastric mucosal inflammatory response but also the pathogenesis of Helicobacter pylori-associated diseases. In the renin-angiotensin system, chymase (CMA) is related to gastric carcinogenesis and angiogenesis in H. pylori-infected patients. We aimed to clarify the association of MMP-7-181 and CMA/B polymorphisms with susceptibility to gastric cancer and cancer progression in H. pylori-infected patients.
METHODS: We assessed the MMP-7-181 and CMA/B polymorphisms in H. pylori-positive patients with gastric cancer (n = 160), gastric ulcer (n = 157), duodenal ulcer (n = 121), and H. pylori-positive gastritis alone as controls (n = 156).
RESULTS: For gastric cancer risk, the age-and sex-adjusted odds ratio (OR) of the MMP-7-181 G allele carrier relative to the A/A genotype was significantly increased [OR, 2.32; 95% confidence interval (CI), 1.24-4.35], especially in patients with noncardia cancer (OR, 2.31; 95% CI, 1.22-4.36) and those with clinical stage III or IV cancer (OR, 3.66; 95% CI, 1.54-8.73). Carriage of the CMA/B A allele was significantly associated with gastric cancer development (OR, 1.73; 95% CI, 1.10-2.71). Simultaneous carriage of both the MMP-7-181 G allele and the CMA/B A allele dramatically increased the gastric cancer risk (OR, 8.18; 95% CI, 2.79-23.93).
CONCLUSIONS: In Japan, carriage of the MMP-7-181 G allele and of the CMA/B A allele were each associated with an increased risk for H. pylori-related noncardia gastric cancer development. MMP-7-181 and CMA/B genotyping tests might be useful tools for screening for individuals with higher gastric cancer risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958543     DOI: 10.1007/s00535-008-2221-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  51 in total

1.  Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.

Authors:  Giorgio Ghilardi; Maria Luisa Biondi; Maddalena Erario; Emma Guagnellini; Roberto Scorza
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

2.  The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism.

Authors:  Christoph Röcken; Uwe Lendeckel; Jutta Dierkes; Sabine Westphal; Stacy Carl-McGrath; Brigitte Peters; Sabine Krüger; Peter Malfertheiner; Albert Roessner; Matthias P A Ebert
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

3.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism.

Authors:  S Ye; S Dhillon; S J Turner; A C Bateman; J M Theaker; R M Pickering; I Day; W M Howell
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Naohito Shirai; Mutsuhiro Ikuma; Haruhiko Sugimura; Akira Hishida
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

7.  Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis.

Authors:  Keisaku Kondo; Michiko Muramatsu; Yukiko Okamoto; Denan Jin; Shinji Takai; Nobuhiko Tanigawa; Mizuo Miyazaki
Journal:  J Surg Oncol       Date:  2006-01-01       Impact factor: 3.454

8.  Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.

Authors:  Shioto Suzuki; Youko Muroishi; Isao Nakanishi; Yoshio Oda
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

9.  Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; J A McKay; W T Melvin; J E Fothergill
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

10.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

View more
  9 in total

1.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

Review 2.  Role of renin-angiotensin system in gastric oncogenesis.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka; Naohito Shirai; Takahisa Furuta
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

3.  No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.

Authors:  Alicia Beeghly-Fadiel; Yong-Bing Xiang; Sandra L Deming; Ji-Rong Long; Wang-Hong Xu; Qiuyin Cai; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-12       Impact factor: 4.254

Review 4.  Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.

Authors:  Xiaoying Li; Lianxi Qu; Yu Zhong; Yingjie Zhao; Hongyan Chen; Lu Daru
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-05       Impact factor: 4.553

5.  A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.

Authors:  Jing Wu; Xuan Guan; Kui Zhang; Ya-Ting Li; Peng Bai; Jin Wu
Journal:  Biomed Rep       Date:  2013-07-11

6.  Inferring serum proteolytic activity from LC-MS/MS data.

Authors:  Piotr Dittwald; Jerzy Ostrowski; Jakub Karczmarski; Anna Gambin
Journal:  BMC Bioinformatics       Date:  2012-04-12       Impact factor: 3.169

Review 7.  Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review.

Authors:  Edyta Wieczorek; Ewa Jablonska; Wojciech Wasowicz; Edyta Reszka
Journal:  Tumour Biol       Date:  2014-10-29

8.  ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Mohammad Zare; Jamal Jafari-Nedooshan; Kazem Aghili; Hossein Ahrar; Mohammad Hossein Jarahzadeh; Neda Seifi-Shalamzari; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arq Bras Cir Dig       Date:  2019-10-21

Review 9.  Matrix Metalloproteinases in Helicobacter pylori-Associated Gastritis and Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.